These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis. Campagnuolo G, Bolon B, Feige U. Arthritis Rheum; 2002 Jul; 46(7):1926-36. PubMed ID: 12124878 [Abstract] [Full Text] [Related]
3. The effects of glucosamine hydrochloride on subchondral bone changes in an animal model of osteoarthritis. Wang SX, Laverty S, Dumitriu M, Plaas A, Grynpas MD. Arthritis Rheum; 2007 May; 56(5):1537-48. PubMed ID: 17469133 [Abstract] [Full Text] [Related]
4. N-acylated glucosamines for bone and joint disorders: effects of N-butyryl glucosamine on ovariectomized rat bone. Anastassiades T, Rees-Milton K, Xiao H, Yang X, Willett T, Grynpas M. Transl Res; 2013 Aug; 162(2):93-101. PubMed ID: 23680489 [Abstract] [Full Text] [Related]
5. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Koufany M, Moulin D, Bianchi A, Muresan M, Sebillaud S, Netter P, Weryha G, Jouzeau JY. Arthritis Res Ther; 2008 Aug; 10(1):R6. PubMed ID: 18199331 [Abstract] [Full Text] [Related]
6. Bone protective effect of simvastatin in experimental arthritis. Funk JL, Chen J, Downey KJ, Clark RA. J Rheumatol; 2008 Jun; 35(6):1083-91. PubMed ID: 18464303 [Abstract] [Full Text] [Related]
8. Effect of methotrexate therapy on bone mineral density and body composition in rat adjuvant arthritis. Morgan SL, Chen DT, Carlee J, Baggott JE. J Rheumatol; 2004 Sep; 31(9):1693-7. PubMed ID: 15338486 [Abstract] [Full Text] [Related]
10. Effect of intermittent administration of human parathyroid hormone on bone mineral density and arthritis in rats with collagen-induced arthritis. Fukata S, Hagino H, Okano T, Yamane I, Kameyama Y, Teshima R. Arthritis Rheum; 2004 Dec; 50(12):4060-9. PubMed ID: 15593226 [Abstract] [Full Text] [Related]
11. NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis. Francis MD, Hovancik K, Boyce RW. Int J Tissue React; 1989 Dec; 11(5):239-52. PubMed ID: 2517540 [Abstract] [Full Text] [Related]
12. Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation. Smith BJ, Lerner MR, Bu SY, Lucas EA, Hanas JS, Lightfoot SA, Postier RG, Bronze MS, Brackett DJ. Bone; 2006 Mar; 38(3):378-86. PubMed ID: 16256450 [Abstract] [Full Text] [Related]
13. Slow-release clodronate in prevention of inflammation and bone loss associated with adjuvant arthritis. Osterman T, Virtamo T, Laurén L, Kippo K, Pasanen I, Hannuniemi R, Väänänen K, Sellman R. J Pharmacol Exp Ther; 1997 Feb; 280(2):1001-7. PubMed ID: 9023317 [Abstract] [Full Text] [Related]
16. Single dose pharmacokinetics and bioavailability of butyryl glucosamine in the rat. Aghazadeh-Habashi A, Ibrahim A, Carran J, Anastassiades T, Jamali F. J Pharm Pharm Sci; 2006 Feb; 9(3):359-64. PubMed ID: 17207418 [Abstract] [Full Text] [Related]